Daxor (DXR) vs SANUWAVE Health (SNWV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Daxor (DXR) has outperformed SANUWAVE Health (SNWV) over the past year, losing 20.0% versus a loss of 81.3%. Daxor is the larger company by market cap ($61.2 million vs $48.7 million), about 1.3 times the size. On valuation, Daxor trades at a lower trailing P/E (9.5x vs 23.6x for SANUWAVE Health).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DXR | SNWV |
|---|---|---|
| Share price | $10.49 | $5.66 |
| Market cap | $61.21M | $48.69M |
| 1-day change | +0.24% | -3.17% |
| YTD return | -29.08% | -80.41% |
| 1-year return | -20.03% | -81.34% |
| 5-year return | -7.02% | — |
| P/E ratio (TTM) | 9.53 | 23.58 |
| EPS (TTM) | $1.10 | $0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.76 | $36.42 |
| 52-week low | $8.56 | $3.92 |
| Distance from 52-week high | -28.96% | -84.46% |
| Analyst consensus | none | — |
| Avg. price target upside | +90.75% | — |
| Average volume | 17.27K | 134.20K |
| Shares outstanding | 5.84M | 8.60M |
| Employees | — | 55 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DXR has outperformed SNWV by 61.3 percentage points over the past year.
- SANUWAVE Health trades at a higher earnings multiple (23.6x vs 9.5x trailing P/E).
About Daxor
DXR stock →Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Health Care · Medical/Dental Instruments
About SANUWAVE Health
SNWV stock →SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally.
Health Care · Medical/Dental Instruments · 55 employees
DXR vs SNWV FAQ
Which is bigger, Daxor or SANUWAVE Health?
Daxor (DXR) is larger, with a market capitalization of $61.21M compared with $48.69M for SANUWAVE Health (SNWV).
Which stock has performed better over the past year, DXR or SNWV?
DXR returned -20.03% over the past 12 months, compared with -81.34% for SNWV (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DXR or SNWV?
DXR has the lower trailing P/E at 9.5, versus 23.6 for SNWV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Daxor and SANUWAVE Health in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.